Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Can POLB 001 Revolutionize CRS Treatment in Cancer Immunotherapy?
Research & Development Can POLB 001 Revolutionize CRS Treatment in Cancer Immunotherapy?

In a significant breakthrough, Poolbeg Pharma announced positive pre-clinical study results for their drug POLB 001, presented at the 66th American Society of Hematology (ASH) Annual Meeting. The study focused on the drug's potential to prevent Cytokine Release Syndrome (CRS), a frequently

Is Ocaliva Still Safe for PBC Patients Amid Rising Liver Injury Cases?
Research & Development Is Ocaliva Still Safe for PBC Patients Amid Rising Liver Injury Cases?

A drug initially celebrated for its potential in treating a rare liver disease has come under scrutiny following alarming safety findings. Ocaliva, developed by Intercept Pharmaceuticals and now under Alfasigma's ownership, was initially viewed as a breakthrough treatment for primary biliary

Unlocking Cancer Therapy: Overcoming Hypoxia-Induced Resistance
Research & Development Unlocking Cancer Therapy: Overcoming Hypoxia-Induced Resistance

Advancements in cancer therapy have brought significant hope, especially with immune checkpoint blockades (ICBs), providing a groundbreaking treatment strategy for advanced cancers. Despite this, the effectiveness of ICBs has often been thwarted by therapeutic resistance, which renders

Can Innovative Tech Improve Long-Term Outcomes in Pediatric AE?
Research & Development Can Innovative Tech Improve Long-Term Outcomes in Pediatric AE?

Autoimmune encephalitis (AE), a condition where the body's immune system turns against the brain, affects approximately one-third of global encephalitis cases and often leads to debilitating symptoms, including seizures, cognitive impairment, and motor dysfunctions. Despite advancements in

Global Trends in Ovarian Cancer Incidence and Histological Subtypes Analysis
Research & Development Global Trends in Ovarian Cancer Incidence and Histological Subtypes Analysis

Ovarian cancer represents a significant health concern worldwide, being the eighth most frequently diagnosed cancer and the leading cause of cancer-related mortality among women globally. In 2022 alone, the disease accounted for over 324,000 new cases and 206,839 deaths across the globe. This

How Will New HIV Guidelines Change Treatment and Prevention?
Research & Development How Will New HIV Guidelines Change Treatment and Prevention?

The International Antiviral (formerly AIDS) Society-USA (IAS-USA) has unveiled comprehensive international guidelines for the treatment and prevention of HIV, coinciding with the observance of World AIDS Day on December 1, 2024. These guidelines were meticulously developed by a panel of volunteer

Can GLP-1 Receptor Agonists Transform MASLD Treatment Effectiveness?
Research & Development Can GLP-1 Receptor Agonists Transform MASLD Treatment Effectiveness?

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease, has become a major global health concern. Characterized by hepatic steatosis and associated with at least one cardiometabolic risk factor such as type 2 diabetes mellitus (T2DM),

Reiki Therapy Shows Significant Benefits for Cancer Infusion Patients
Research & Development Reiki Therapy Shows Significant Benefits for Cancer Infusion Patients

Researchers at University Hospitals Connor Whole Health recently conducted a comprehensive study to determine the impact of Reiki therapy on cancer outpatients undergoing infusion treatments. In particular, the study focused on assessing improvements in symptoms such as pain, fatigue, anxiety,

Impact of Social Risks on Cancer Screening Among Underserved Communities
Research & Development Impact of Social Risks on Cancer Screening Among Underserved Communities

The relationship between social risks and routine cancer screenings signifies a complex and pressing public health issue, particularly regarding how housing instability or food insecurity among patients significantly hinders essential cancer preventive care. A new study conducted by researchers at

Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes
Research & Development Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes

In a groundbreaking study from Karolinska Institutet in Sweden, researchers have introduced an innovative method aimed at concurrently screening for liver fibrosis and eye disease in people living with type 2 diabetes. By combining liver damage screening with the already established retina scanning

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later